glaucoma – Medxy AI

Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics

By MedXY 09/09/2026

This review synthesizes recent evidence on event-based progression detection in glaucoma, highlighting that OCTA vessel density may identify progression earlier than structural OCT or visual field testing, with important implications for clinical monitoring and risk stratification.

news Ophthalmology

Long-Term Incidence and Risk Factors for Glaucoma: Insights from the Gangnam Eye Cohort Study

By MedXY 08/31/2026

A 10-year Korean cohort study reveals that retinal arteriosclerosis, intraocular pressure, age, serum uric acid, and cholesterol levels significantly increase the risk of structural glaucoma conversion.

news Ophthalmology

IOP Stress Testing Identifies Glaucoma Eyes at Risk of Fast Progression Despite Controlled Office Pressure

By MedXY 08/28/2026

A stress test measuring intraocular pressure identifies glaucoma patients at risk of rapid progression despite normal office pressure readings, offering complementary prognostic insights beyond routine checks.

news Ophthalmology

Long-Term Efficacy and Visual Field Outcomes of Selective Laser Trabeculoplasty in Glaucoma Management

By MedXY 08/26/2026

This study evaluates long-term outcomes of selective laser trabeculoplasty (SLT) in controlling intraocular pressure and preventing visual field deterioration, identifying clinical factors influencing effectiveness and progression risk.

news Ophthalmology

Impact of Trabeculectomy versus Medical Therapy on Visual Field and Quality of Life in Advanced Glaucoma: Insights from the TAGS Study

By MedXY 08/24/2026

The TAGS Study shows trabeculectomy slows visual field loss more effectively than medical treatment in advanced glaucoma, yet this did not translate into significant quality-of-life improvements over five years, highlighting limitations in current patient-reported outcome measures.

news Ophthalmology

Visual Electrophysiology in Glaucoma: Key Findings from the 2026 American Academy of Ophthalmology Report

By MedXY 07/13/2026

The AAO 2026 report reviews evidence for ERG and VEP tests in glaucoma, finds promising tools (PERG, PhNR, mfVEP) but stops short of routine use — recommending selective, adjunctive use pending standardization and stronger evidence.

news Ophthalmology

Evaluating the Clinical Utility of 10-2 Visual Field Testing in Early Glaucoma Progression Detection

By MedXY 07/09/2026

This study assesses the added value of 10-2 visual field testing compared to the 24-2 test in detecting progression of early glaucoma, highlighting its role in patients with localized central visual field loss.

news Ophthalmology

Enhancing Glaucoma Diagnosis in Myopia: Validating OCT-Based Prespecified Rules for Optic Neuropathy Detection

By MedXY 07/05/2026

This multicenter study validates prespecified OCT diagnostic rules demonstrating high accuracy in detecting glaucomatous optic neuropathy in nonpathologic myopic eyes, offering improved clinical decision support across diverse populations.

news Ophthalmology

Enhancing Glaucoma Research Accuracy: Contrasting Diagnostic and Treatment-Based Definitions in UK Biobank

By MedXY 06/29/2026

This study compares diagnostic-only versus combined diagnostic and treatment-based definitions of glaucoma in UK Biobank participants, revealing stronger associations of risk factors and severity biomarkers with definitions including treatment evidence, thereby informing future glaucoma research in population cohorts.

news Ophthalmology

Intraoperative Intravitreal Bevacizumab Extended Trabeculectomy Survival to 3 Years in a Randomized Trial

By MedXY 05/20/2026

A double-blind randomized trial found that a single intraoperative intravitreal bevacizumab injection improved 3-year trabeculectomy survival and reduced postoperative medication needs versus placebo.

news Ophthalmology Public Health

Delayed Glaucoma Follow-Up Was Usually Not Linked to Visual Field Progression, but Longer Gaps May Matter in More Advanced Disease

By MedXY 05/18/2026

In a large retrospective glaucoma cohort, delayed follow-up was common yet was not generally associated with visual field worsening, although longer delays appeared more consequential in eyes with worse baseline visual field loss.

news Ophthalmology

Personalized Glaucoma Coaching Boosts Medication Adherence by 20%: SEE Program Trial Results

By MedXY 04/23/2026

A 6-month personalized coaching program (SEE) significantly improved glaucoma medication adherence by 19.7% compared to standard education, reducing vision loss risk in a randomized trial of 235 patients.

news Ophthalmology

Association of Deep Optic Nerve Head Structural Remodeling with Choroidal Microvasculature Dropout in Glaucoma with and without Myopia

By MedXY 04/21/2026

Study reveals significant links between optic nerve head structural changes and choroidal microvascular dropout in glaucomatous eyes, particularly in myopia. Deep structural parameters like neural canal geometry strongly correlate with microvascular damage severity.

news Ophthalmology

Microvascular Dropout and Parapapillary Atrophy Progression Predict Structural Optic Disc Damage in Glaucoma Suspects

By MedXY 03/30/2026

A 19-year retrospective study reveals that microvascular dropout and β-zone parapapillary atrophy progression are powerful independent predictors of structural optic disc damage in glaucoma suspects, even when visual fields remain stable.

news Ophthalmology

Microvascular Dropout as a Potent Biomarker for Structural Progression in Glaucoma Suspects

By MedXY 03/16/2026

A retrospective cohort study reveals that microvascular dropout (MvD) and β-zone parapapillary atrophy (PPA) progression are significant independent predictors of structural optic disc damage in glaucoma suspect eyes, identifying risk long before the onset of perimetric visual field loss.

Clinical Updates news Ophthalmology

Optimizing Glaucoma Management through Behavioral Intervention: Insights from the SEE Randomized Clinical Trial

By MedXY 02/26/2026

The SEE randomized clinical trial demonstrates that a 6-month personalized coaching program using motivational interviewing significantly improves glaucoma medication adherence and reduces patient distress compared to standard education.

news Ophthalmology

The 22 mm Hg Threshold: Does a Historical Cutoff Still Dictate Modern Glaucoma Management?

By MedXY 01/17/2026

A multicenter cohort study of 1.8 million clinic encounters reveals that while clinicians view intraocular pressure as a continuous risk factor, the historical 22 mm Hg cutoff remains a significant psychological trigger for escalating glaucoma treatment.

news Ophthalmology

Which Patients with Open-Angle Glaucoma Progress Faster? Key Prognostic Factors from a Cochrane Synthesis

By MedXY 12/15/2025

A Cochrane review of 22 cohort studies (6,082 patients) found bilateral disease, disc haemorrhage, female sex, and active treatment have the most consistent associations with visual-field progression in open-angle glaucoma, but overall evidence quality is limited.

news Ophthalmology Pediatrics

Five-Year Visual Outcomes After Lensectomy for Childhood Traumatic Cataract: Modest Vision Gains but High Rates of Visual Axis Opacification in Pseudophakia

By MedXY 11/25/2025

A prospective PEDIG cohort found modest long-term vision after lensectomy for pediatric traumatic cataract, low 5-year glaucoma prevalence, and high 5-year surgery rates for visual axis opacification in pseudophakic eyes, especially without anterior vitrectomy.

Clinical Updates news Ophthalmology Specialties

Nonmedical Factors Impacting Quality of Care in Newly Diagnosed Primary Open-Angle Glaucoma Patients

By MedXY 09/28/2025

This study reveals that socioeconomic status, residential location, and household composition significantly affect treatment outcomes and follow-up in newly diagnosed POAG patients, highlighting the need for targeted strategies to improve glaucoma care equity.